NR Dosage: How Much, When and How to Take It

There is no proven universal nicotinamide riboside dosage for slowing human aging. Published NR studies have tested amounts ranging from small single doses to supervised multi-gram regimens. Those experiments answer different questions; a higher study dose is not automatically a better daily supplement choice. ^{[1] [2] [3]}

The practical task is to separate three things: the amount on a particular label, the exposure used in a particular study, and an appropriate decision for an individual. This guide also covers timing, food, divided doses and storage without turning uncertain details into rigid rules.

What doses have human studies actually used?

The acute PK study was small; the escalation study included eight volunteers. These are not large long-term comparisons of daily consumer routines. The title of the eight-week trial uses “long-term,” but its duration should still be described as eight weeks, rather than years. ^{[1] [4] [2] [3] [5]}

The table describes research exposures, not a recommendation to reproduce them. Population, formulation, medical supervision, exclusion criteria and the chosen endpoint all matter.

Is 300 mg a good NR dose?

Three hundred milligrams is a common retail strength and one of the amounts tested in the dose-response study. That makes it easier to relate a label to biomarker evidence. It does not establish 300 mg as the optimal amount for every adult, nor prove a benefit for fatigue, cognition or lifespan.

In that study, reported whole-blood NAD+ increases at two weeks were about 22%, 51% and 142% for 100, 300 and 1,000 mg/day. The larger biomarker response at the highest amount did not establish a corresponding clinical benefit. No validated rule says that each additional percentage increase translates into more healthy years. ^[2]

The distinction is particularly important for a buyer tempted to double intake after failing to feel an effect. A subjective response, a blood metabolite response and a clinical outcome are different measurements. More exposure may increase cost or adverse effects without addressing the original goal.

What about 500, 700 or 1,000 mg?

A number printed on a bottle is a unit or serving amount, not an evidence grade. First identify whether it is per capsule or per serving, and how many capsules make a serving. Then identify whether the quantity describes NR, an NR salt or a multi-ingredient complex.

For example, the current Thorne labels list NR hydrogen malate, while much of the human literature concerns NR chloride. Four hundred fifteen milligrams of one salt should not be treated as automatically identical to the same mass of another preparation. The forms comparison explains the chemistry and evidence limits.

DoNotAge's current page presents another practical issue: its title mentions 300 mg, while the main body and FAQ state 350 mg per capsule or scoop and a 700 mg daily serving. Our product review reports that inconsistency. Confirm the actual current bottle and regional option before calculating intake; the contradiction should not be silently resolved by choosing whichever number sounds preferable.

Capsule arithmetic without accidental dose escalation

If a confirmed label supplies 300 mg per capsule, two capsules supply 600 mg of that declared ingredient. If a confirmed label lists 300 mg per two-capsule serving, two capsules supply 300 mg. The capsule count is identical while the intake differs twofold.

The last row intentionally keeps the salt name. A dose calculation should preserve the declared basis instead of quietly converting the number into “pure NR.” A separate supplier specification would be needed to establish a product's NR-equivalent amount reliably.

Also add up overlapping products. A standalone NR capsule, a longevity blend and a multivitamin containing NR can create a total that is larger than any single label suggests. The same audit should include co-ingredients, especially when formulas contain several sources of betaine or polyphenols.

Morning or night: what is the best time to take NR?

There is no established human clinical result showing that a particular clock time maximizes NR's health benefits. Circadian biology provides a rationale for research, but it does not turn a morning preference into a proven anti-aging protocol.

For a person who has decided to use the supplement appropriately, following the exact product instructions and maintaining a practical routine is more defensible than chasing an unsupported time window. If a product appears associated with sleep disturbance, review the timing, total formula and other causes rather than assuming the effect is evidence of rejuvenation.

A morning routine may be convenient. An evening routine is not automatically ineffective. The relevant evidence would be a direct comparison of schedules on a meaningful outcome, with formulation and total intake held constant. Such a superiority claim is not established by the studies summarized here.

With food or on an empty stomach?

Use the instructions for the actual product. Available research does not establish a universal food rule that guarantees better clinical outcomes across all NR formulations. Trial administration details explain how an experiment was conducted; they do not necessarily identify the only effective consumer routine.

For someone who experiences nausea or abdominal discomfort, taking a supplement with a meal may be a practical tolerability discussion with a pharmacist or clinician, provided the label allows it. That is different from claiming that food doubles absorption or that an empty stomach is required for brain uptake.

Powder directions also need care. Do not assume a household teaspoon has the same mass as the supplied scoop, or that every powder has the same concentration. A scoop is a product-specific measuring device, not a universal dose unit.

Should NR be split into two doses?

Several disease studies used divided doses, while other trials used once-daily administration. Those differences do not establish that splitting is always better. A particular schedule may reflect the study protocol, intended exposure or tolerability rather than a proven advantage over every alternative.

NOPARK used 500 mg twice daily for 52 weeks and did not establish disease modification. Its divided schedule therefore cannot be marketed as a successful Parkinson's regimen. ^[5]

If a clinician recommends an individualized routine, follow that plan. Do not use the existence of a twice-daily study as a reason to double a once-daily product serving. Total amount and frequency must both be explicit.

Half-life does not determine clinical benefit by itself

NR, nicotinamide, NAD+ and downstream metabolites have different time courses. A short plasma appearance of the parent molecule does not prove that supplementation must be repeated every few hours, because intracellular metabolism and downstream pools are part of the exposure.

Conversely, a sustained blood NAD+ increase does not establish that all tissues remain optimally supplied or that daily use indefinitely is necessary. Early PK work helps characterize the metabolome; it does not define a universal dosing interval for every clinical purpose. ^{[1] [4]}

A meaningful dosing comparison would measure the appropriate exposure and the intended outcome. Selecting a schedule solely from a parent-compound half-life can give an appearance of precision without establishing usefulness.

Missed doses, cycling and tolerance

The evidence does not establish an optimal “five days on, two days off” schedule or a need to cycle NR to prevent tolerance. Such schedules may be personal habits or marketing protocols rather than tested improvements in efficacy or safety.

For a missed dose, consult the product instructions or a pharmacist rather than automatically doubling the next amount. Creating an intermittent high-dose pattern is not equivalent to the daily regimen used in a study.

If use continues, periodically reassess the original reason, tolerability, overlapping products and cost. Continuing because a supplement has become part of a routine is different from continuing because there is a meaningful, measured benefit.

Storage and stability

Keep the product in its original packaging and follow its stated storage conditions. Heat, moisture, formulation and packaging can affect stability; a research result for one crystalline salt or solution does not define the shelf life of every retail powder.

DoNotAge's current instructions say to store the product cool and dry, away from direct sunlight and excessive heat, without refrigeration. Other products may differ. Opening capsules, premixing powder for prolonged storage or transferring it to an unsealed container can move beyond the manufacturer's tested conditions.

If the product has changed appearance, packaging is damaged or storage history is uncertain, ask the manufacturer about the lot. Do not infer potency from taste or assume that a purity percentage at manufacture guarantees the same assay after poor storage.

Is a high dose safer because a trial used it?

NR-SAFE tested 3,000 mg/day for four weeks in people with Parkinson's disease under study supervision. It provides useful short-term information, but its size and duration cannot establish indefinite high-dose safety in every population. ^[3]

Similarly, a year-long trial in a defined disease population is not a lifetime safety study in healthy adults. Medication use, organ disease, pregnancy, breastfeeding and childhood require separate consideration. A historical food-use assessment also concerns specified conditions, not unrestricted dosing. ^[6]

The side-effects and safety guide explains these boundaries. When the intended benefit is uncertain, increasing exposure is not an evidence-based substitute for clarifying the goal.

A practical decision before starting

Write down the exact product, declared ingredient basis, daily amount, purpose and reassessment point. Check medicines and all co-ingredients when relevant. If the goal involves a diagnosed condition, the supplement should be discussed within that condition's care plan.

Then compare the goal with the human-benefits evidence. A biomarker effect may be interesting, but a product that raises NAD+ is not thereby proven to improve the outcome you care about. The most useful dose is not the biggest number; it is an amount justified by the actual situation, with its uncertainty understood.